TipRanks
Advertisement
Advertisement

DE:MAR Stock Latest News

Maravai Lifesciences’ TriLink BioTechnologies secures CleanCap China patent
The FlyMaravai Lifesciences’ TriLink BioTechnologies secures CleanCap China patent
1d ago
MRVI
Maravai Lifesciences initiated with a Neutral at UBS
PremiumThe Fly
Maravai Lifesciences initiated with a Neutral at UBS
21d ago
MRVI
Stifel sees Moderna data as positive for Repligen, Maravai
PremiumThe Fly
Stifel sees Moderna data as positive for Repligen, Maravai
1M ago
MRNA
MRVI
Wells sees Repligen among key beneficiaries of Moderna’s cancer vaccine data
PremiumThe Fly
Wells sees Repligen among key beneficiaries of Moderna’s cancer vaccine data
1M ago
DHR
MRK
Maravai Lifesciences Earnings Call Highlights Margin Rebound
PremiumCompany Announcements
Maravai Lifesciences Earnings Call Highlights Margin Rebound
1M ago
MRVI
Closing Bell Movers: Doximity soars after quarterly report
PremiumThe FlyClosing Bell Movers: Doximity soars after quarterly report
2M ago
DV
DBX
Maravai Lifesciences sees FY26 revenue $205M-$215M, consensus $208.6M
Premium
The Fly
Maravai Lifesciences sees FY26 revenue $205M-$215M, consensus $208.6M
2M ago
MRVI
Maravai Lifesciences reports Q2 EPS (8c), consensus (4c)
Premium
The Fly
Maravai Lifesciences reports Q2 EPS (8c), consensus (4c)
2M ago
MRVI
Maravai’s TrinLink BioTechnologies granted new patent in China
PremiumThe Fly
Maravai’s TrinLink BioTechnologies granted new patent in China
2M ago
MRVI
Maravai Lifesciences announces opening of GMP enzyme manufacturing facility
PremiumThe Fly
Maravai Lifesciences announces opening of GMP enzyme manufacturing facility
4M ago
MRVI
Maravai LifeSciences Refinances Debt, Extends Credit Facilities
PremiumCompany Announcements
Maravai LifeSciences Refinances Debt, Extends Credit Facilities
4M ago
8K
MRVI
Maravai Lifesciences announces refinancing of credit agreement
PremiumThe Fly
Maravai Lifesciences announces refinancing of credit agreement
4M ago
MRVI
Maravai Lifesciences Shareholders Back Board, Pay, Auditor
PremiumCompany AnnouncementsMaravai Lifesciences Shareholders Back Board, Pay, Auditor
4M ago
8K
MRVI
Maravai Lifesciences Signals Turnaround in Earnings Call
Premium
Company Announcements
Maravai Lifesciences Signals Turnaround in Earnings Call
5M ago
MRVI
Maravai Lifesciences price target raised to $6 from $4.50 at Deutsche Bank
Premium
The Fly
Maravai Lifesciences price target raised to $6 from $4.50 at Deutsche Bank
5M ago
MRVI
Maravai Lifesciences reports Q1 EPS 1c, consensus (5c)
PremiumThe Fly
Maravai Lifesciences reports Q1 EPS 1c, consensus (5c)
5M ago
MRVI
Maravai Lifesciences sees FY26 revenue $205M-$215M, consensus $204.9M
PremiumThe Fly
Maravai Lifesciences sees FY26 revenue $205M-$215M, consensus $204.9M
5M ago
MRVI
Maravai Lifesciences Charts Early Turnaround in 2025
PremiumCompany Announcements
Maravai Lifesciences Charts Early Turnaround in 2025
7M ago
MRVI
Maravai Lifesciences price target raised to $3 from $2 at Baird
PremiumThe Fly
Maravai Lifesciences price target raised to $3 from $2 at Baird
7M ago
MRVI
Balanced Risk/Reward Leads to Hold Rating as Restructuring Progress Offsets Ongoing Revenue Pressures
PremiumRatingsBalanced Risk/Reward Leads to Hold Rating as Restructuring Progress Offsets Ongoing Revenue Pressures
7M ago
MRVI
Maravai Lifesciences reports Q4 adjusted EPS (4c), consensus (7c)
Premium
The Fly
Maravai Lifesciences reports Q4 adjusted EPS (4c), consensus (7c)
7M ago
MRVI
Maravai Lifesciences sees FY26 revenue $200M-$210M, consensus $203.26M
Premium
The Fly
Maravai Lifesciences sees FY26 revenue $200M-$210M, consensus $203.26M
7M ago
MRVI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >